Hypervariable epitope constructs as a means of accounting for epitope variability

David E. Anderson, Arthur Malley, Eli Benjamini, Murray B. Gardner, Jose V Torres

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Epitope variability is one of the greatest obstacles to development of synthetic peptide vaccines. Based on a recently described hypervariable epitope (aa 414-434) on the envelope glycoprotein (gp130) to simian immunodeficiency virus (SIV mac 142), we have developed a novel approach to account for epitope variability. We have prepared, in a single synthesis, a cocktail of peptides, designated a hypervariable epitope construct (HEC), which collectively represent all the in vivo variability seen in an epitope. The HEC represents permutations of amino acid substitutions found in the epitope and has been able to induce antibodies with enhanced binding to native SIV and broad immunoreactivity to related epitope analogues.

Original languageEnglish (US)
Pages (from-to)736-740
Number of pages5
JournalVaccine
Volume12
Issue number8
DOIs
StatePublished - 1994

Fingerprint

epitopes
Epitopes
synthetic vaccines
Simian immunodeficiency virus
Synthetic Vaccines
Subunit Vaccines
subunit vaccines
synthetic peptides
amino acid substitution
Amino Acid Substitution
glycoproteins
Glycoproteins
peptides
Peptides
antibodies
synthesis
Antibodies

Keywords

  • epitope variability
  • Hypervariable epitope constructs
  • simian immunodeficiency virus

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Hypervariable epitope constructs as a means of accounting for epitope variability. / Anderson, David E.; Malley, Arthur; Benjamini, Eli; Gardner, Murray B.; Torres, Jose V.

In: Vaccine, Vol. 12, No. 8, 1994, p. 736-740.

Research output: Contribution to journalArticle

Anderson, David E. ; Malley, Arthur ; Benjamini, Eli ; Gardner, Murray B. ; Torres, Jose V. / Hypervariable epitope constructs as a means of accounting for epitope variability. In: Vaccine. 1994 ; Vol. 12, No. 8. pp. 736-740.
@article{4cbf91e672044f2d859fe724909967e5,
title = "Hypervariable epitope constructs as a means of accounting for epitope variability",
abstract = "Epitope variability is one of the greatest obstacles to development of synthetic peptide vaccines. Based on a recently described hypervariable epitope (aa 414-434) on the envelope glycoprotein (gp130) to simian immunodeficiency virus (SIV mac 142), we have developed a novel approach to account for epitope variability. We have prepared, in a single synthesis, a cocktail of peptides, designated a hypervariable epitope construct (HEC), which collectively represent all the in vivo variability seen in an epitope. The HEC represents permutations of amino acid substitutions found in the epitope and has been able to induce antibodies with enhanced binding to native SIV and broad immunoreactivity to related epitope analogues.",
keywords = "epitope variability, Hypervariable epitope constructs, simian immunodeficiency virus",
author = "Anderson, {David E.} and Arthur Malley and Eli Benjamini and Gardner, {Murray B.} and Torres, {Jose V}",
year = "1994",
doi = "10.1016/0264-410X(94)90225-9",
language = "English (US)",
volume = "12",
pages = "736--740",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - Hypervariable epitope constructs as a means of accounting for epitope variability

AU - Anderson, David E.

AU - Malley, Arthur

AU - Benjamini, Eli

AU - Gardner, Murray B.

AU - Torres, Jose V

PY - 1994

Y1 - 1994

N2 - Epitope variability is one of the greatest obstacles to development of synthetic peptide vaccines. Based on a recently described hypervariable epitope (aa 414-434) on the envelope glycoprotein (gp130) to simian immunodeficiency virus (SIV mac 142), we have developed a novel approach to account for epitope variability. We have prepared, in a single synthesis, a cocktail of peptides, designated a hypervariable epitope construct (HEC), which collectively represent all the in vivo variability seen in an epitope. The HEC represents permutations of amino acid substitutions found in the epitope and has been able to induce antibodies with enhanced binding to native SIV and broad immunoreactivity to related epitope analogues.

AB - Epitope variability is one of the greatest obstacles to development of synthetic peptide vaccines. Based on a recently described hypervariable epitope (aa 414-434) on the envelope glycoprotein (gp130) to simian immunodeficiency virus (SIV mac 142), we have developed a novel approach to account for epitope variability. We have prepared, in a single synthesis, a cocktail of peptides, designated a hypervariable epitope construct (HEC), which collectively represent all the in vivo variability seen in an epitope. The HEC represents permutations of amino acid substitutions found in the epitope and has been able to induce antibodies with enhanced binding to native SIV and broad immunoreactivity to related epitope analogues.

KW - epitope variability

KW - Hypervariable epitope constructs

KW - simian immunodeficiency virus

UR - http://www.scopus.com/inward/record.url?scp=0028199114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028199114&partnerID=8YFLogxK

U2 - 10.1016/0264-410X(94)90225-9

DO - 10.1016/0264-410X(94)90225-9

M3 - Article

VL - 12

SP - 736

EP - 740

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 8

ER -